VXRT - Why Vaxart Shares Popped 78% in April
Vaxart (NASDAQ: VXRT) , the biotech creating tablet-based vaccines, jumped 78.2% last month according to S&P Global Market Intelligence . The increase recovered some of the ground it lost after Phase 1 data from its COVID-19 vaccine disappointed investors in early February. Shares closed the month at $10.78.
Image source: Getty Images.
About three months ago, investors bid shares of Vaxart higher in anticipation of results that it failed to deliver. The company kicked off May by reporting disappointing earnings before the bell on Monday May 3. That triggered a sell-off that erased much of April's gains. Despite the share volatility , the company plows forward.
For further details see:
Why Vaxart Shares Popped 78% in April